| scholarly article | Q13442814 |
| P50 | author | Yukio Ando | Q60911856 |
| Wakaba Fukushima | Q89859699 | ||
| P2093 | author name string | Masahide Yazaki | |
| Yoshiki Sekijima | |||
| Mitsuharu Ueda | |||
| Hiroyuki Hata | |||
| Nagaaki Katoh | |||
| Chihiro Shimazaki | |||
| Shuichi Ikeda | |||
| Sinsuke Iida | |||
| P2860 | cites work | Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study | Q30278687 |
| Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis | Q33151135 | ||
| Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial | Q33256792 | ||
| Phase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosis. | Q33427726 | ||
| Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens | Q33508070 | ||
| Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation. | Q34311781 | ||
| Primary systemic amyloidosis: clinical and laboratory features in 474 cases. | Q34320169 | ||
| Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis | Q35886289 | ||
| Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis | Q36165179 | ||
| Clinical aspects of systemic amyloid diseases. | Q36274065 | ||
| Dangerous small B-cell clones. | Q36516158 | ||
| What do I need to know about immunoglobulin light chain (AL) amyloidosis? | Q38005789 | ||
| Labial salivary gland biopsy for diagnosing immunoglobulin light chain amyloidosis: a retrospective analysis. | Q38629699 | ||
| Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death | Q40362742 | ||
| Bortezomib-dexamethasone versus high-dose melphalan for Japanese patients with systemic light-chain (AL) amyloidosis: a retrospective single-center study. | Q40480703 | ||
| High-dose melphalan and autologous stem cell transplantation for systemic light-chain amyloidosis: a single institution retrospective analysis of 40 cases. | Q41021929 | ||
| The systemic amyloidoses | Q41596634 | ||
| Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective study | Q41645533 | ||
| Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis | Q43189700 | ||
| Autologous stem cell transplantation for AL amyloidosis: adjustment of melphalan dose by factors including BNP. | Q43936667 | ||
| Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis | Q48597012 | ||
| Abdominal subcutaneous fat pad aspiration and bone marrow examination for the diagnosis of AL amyloidosis: the reliability of immunohistochemistry | Q50441841 | ||
| Clinical manifestations at diagnosis in Japanese patients with systemic AL amyloidosis: a retrospective study of 202 cases with a special attention to uncommon symptoms. | Q53077085 | ||
| High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis | Q57218202 | ||
| A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis | Q58029845 | ||
| Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case–control study on 174 patients | Q58029880 | ||
| The role of minor salivary gland biopsy in the diagnosis of systemic amyloidosis: results of a prospective study in 62 patients | Q58190652 | ||
| A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis | Q61657829 | ||
| Guidelines on the management of AL amyloidosis | Q61657832 | ||
| P433 | issue | 2 | |
| P921 | main subject | AL amyloidosis | Q4652470 |
| P304 | page(s) | 181-187 | |
| P577 | publication date | 2017-11-01 | |
| P1433 | published in | Internal Medicine | Q6047666 |
| P1476 | title | Nationwide Survey of 741 Patients with Systemic Amyloid Light-chain Amyloidosis in Japan | |
| P478 | volume | 57 |
Search more.